Evaluating Alcohol Use in Alcoholic Liver Disease
Evaluating Alcohol Use in Alcoholic Liver Disease
This prospective, analytic observational study will investigate alcohol recidivism in
 patients with alcoholic liver disease. All adult subjects presenting with alcoholic liver
 disease are considered for inclusion. Subjects able to give consent are included.
This is a longitudinal observational study. Subjects with a diagnosis of alcoholic liver
 disease (acute alcoholic hepatitis or alcoholic cirrhosis) who present to Weill Cornell
 Medical Center or Columbia University Medical Center New York Presbyterian Hospital or the
 Gastroenterology and Hepatology Clinic will be invited to join this study, which entails a
 survey at baseline and follow-up at 3, 6, 9, 12, 15, and 18 months and then at 2, 5, and 10
 years. Follow-up will consist of a chart review, a phone or in person interview, and most
 recent clinic visit interview for alcohol recidivism. The clinical providers will be blinded
 to the survey results.
Inclusion Criteria:

 -  alcoholic liver disease able to consent

 Exclusion Criteria:

 -  without alcoholic liver disease unable to consent